Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Welsbie |
Description | Enlightening Glaucoma Welsbie Lab — Glaucoma Research at University of California San |
Keywords | N/A |
WebSite | welsbielab.org |
Host IP | 198.49.23.144 |
Location | United States |
Site | Rank |
US$469,623
Last updated: 2023-05-11 00:08:27
welsbielab.org has Semrush global rank of 22,537,887. welsbielab.org has an estimated worth of US$ 469,623, based on its estimated Ads revenue. welsbielab.org receives approximately 54,188 unique visitors each day. Its web server is located in United States, with IP address 198.49.23.144. According to SiteAdvisor, welsbielab.org is safe to visit. |
Purchase/Sale Value | US$469,623 |
Daily Ads Revenue | US$434 |
Monthly Ads Revenue | US$13,005 |
Yearly Ads Revenue | US$156,060 |
Daily Unique Visitors | 3,613 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
welsbielab.org. | A | 7199 | IP: 198.49.23.144 |
welsbielab.org. | A | 7199 | IP: 198.185.159.145 |
welsbielab.org. | A | 7199 | IP: 198.185.159.144 |
welsbielab.org. | A | 7199 | IP: 198.49.23.145 |
welsbielab.org. | NS | 3600 | NS Record: dns2.p05.nsone.net. |
welsbielab.org. | NS | 3600 | NS Record: dns3.p05.nsone.net. |
welsbielab.org. | NS | 3600 | NS Record: dns4.p05.nsone.net. |
welsbielab.org. | NS | 3600 | NS Record: ns01.squarespacedns.com. |
welsbielab.org. | NS | 3600 | NS Record: ns02.squarespacedns.com. |
welsbielab.org. | NS | 3600 | NS Record: ns03.squarespacedns.com. |
welsbielab.org. | NS | 3600 | NS Record: ns04.squarespacedns.com. |
welsbielab.org. | NS | 3600 | NS Record: dns1.p05.nsone.net. |
0 Skip to Content Welsbie Lab Home People Publications Open Menu Close Menu Welsbie Lab Home People Publications Open Menu Close Menu Home People Publications Enlightening Glaucoma Research What We Do Glaucoma is a leading cause of irreversible blindness—caused by the axonal injury and subsequent death of projection neurons called retinal ganglion cells (RGCs). The lab uses perturbative genetic approaches to comprehensively characterize the molecular pathways responsible for RGC death and axon degeneration. The team is developing novel small molecules—and gene therapy-based neuroprotective strategies—to attenuate these deleterious, cell-autonomous pathways. Ultimately, the goal is to develop a neuroprotective therapy to lessen vision loss in glaucoma and other optic neuropathies. In addition, the lab is working on the complementary goal of vision restoration through the use of transplanted stem cell-derived neurons. Our Team Recent Publications Inhibition of GCK-IV kinases dissociates |
HTTP/1.1 301 Moved Permanently Age: 529280 Date: Thu, 28 Oct 2021 14:11:26 GMT Location: https://welsbielab.org/ Server: Squarespace Set-Cookie: crumb=BcNM1jY5HaAUOWEzNzlmZDA1OGQ2Mzk1NDNhMTEzNDVjNzQ0MmI2;Path=/ X-Contextid: h5EYd7ct/2qsT3VSe HTTP/2 200 accept-ranges: bytes age: 560592 content-type: text/html;charset=utf-8 date: Thu, 28 Oct 2021 05:29:34 GMT etag: W/"ea2fd9b12f1f781a711b2e159c9039f3" expires: Thu, 01 Jan 1970 00:00:00 GMT last-modified: Thu, 28 Oct 2021 05:29:34 GMT server: Squarespace set-cookie: crumb=BfN5vw6mhFU1ODk3MmZlMTY4ZTdmZGFmNGQzZGYzN2JkYmFhZmU5;Path=/ strict-transport-security: max-age=0 vary: Accept-Encoding x-content-type-options: nosniff x-contextid: nb9jSLwz/gssnSWPC content-length: 24229 |
WHOIS LIMIT EXCEEDED - SEE WWW.PIR.ORG/WHOIS FOR DETAILS |